Clinical Toxicology 2006
We take discussions about weight loss seriously and approach them with empathy, respect, and a commitment to providing patient-centered care
2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S
elegans Notch proteins, LIN-12 and GLP-1, are functionally redundant for certain cell-cell interactions during embryogenesis [15]
In sum, while mechanistic plausibility is strong and extrapolation from prostate oncology supports the concept of therapeuticwindow expansion, there is presently no highlevel randomized evidence in cervical/gynecologic oncology showing hydrogels expand the therapeutic window (i.e., allowing higher tumor dose or less toxicity at equivalent tumor dose)
But a recent systematic review and meta-analysis conducted to inform international PCOS guideline updates concluded that the evidence supporting inositol for PCOS is limited and inconclusive.17 That doesnt mean it cant help it means outcomes arent predictable, and it shouldnt be positioned as a reliable stand-alone solution
